COMPETITION MATTERS
The Competition Tribunal has reached a R2-million settlement with pharmaceuticals group Adcock Ingram with regards to its proposed merger with BB Investment, a wholly owned subsidiary of the Bidvest Group. The Competition Commission earlier referred a complaint to the tribunal, alleging that Adcock Ingram and other respondents had possibly contravened section 13A(3) of the Competition Act, through the pre-implementation of the merger.
Please enter the email address that you used to subscribe to Research Channel. Your password will be sent to this address.
Don't have any login details?
Free Trial Access